Rejected diet drug is back from the dead
You have to wonder what flavor Kool-Aid they drink on FDA panels, because the same group that rejected a diet drug as "too dangerous" back in 2010 just voted overwhelmingly to approve it anyway.
No, the drug isn't safer. No new studies have been conducted. And the panel admits all the potential risks that caught their attention back in 2010 are still there.
They even admit they don't know what all the risks are yet!
"The risks of the medication are real but the potential benefits seem at this time to trump side effects but in truth only time will tell," panelist Dr. Kenneth Burman was quoted as saying.
Only time will tell? Is this guy for real???? You know what else would tell, Dr. Burman? A LONG-TERM CLINICAL TRIAL!
The panel did actually ask for one, but said the company can conduct it AFTER the drug is approved. Approve first, ask questions later -- and you get to play guinea pig in the meantime.
But we don't have to wait for that trial to understand the risks of this dangerous concoction. Qnexa is actually a mix of two older drugs already on the market -- and already linked to plenty of risks.
For kick, it packs phentermine, a drug that basically acts as an amphetamine in the body. This stuff can get your heart racing like a stock car and cause your blood pressure to shoot to the moon.
Long-term heart risk? Try not to think about it.
The other drug is topiramate, an anticonvulsant that happens to have suppressed appetite as a side effect. Want to know some of the other side effects? Memory loss, confusion, mood problems, depression and suicide -- just to name a few.
No amount of weight loss is worth putting up with all that, which is why a whopping 40 percent of patients in one clinical trial dropped out.
If you need to shed pounds, there's still just one tried-and true way to do it without risking your life. You know what's coming next, right? Stop eating junk. Stop the carbs. Stop the sugar.
Simple, yes. But it works.